Glenmark Initiates US Plant Cutback, Pins Hopes On gFlovent, Other Filings

 
• By Anju Ghangurde

Glenmark impairs oral solid dosage and nebulizer blocks at US manufacturing site amid tough market conditions. Can the firm's thrust on injectables and new respiratory filings including for generic Flovent, alongside leadership change, lift the US business?

Glenmark seeks to restore momentum in the US business • Source: Shutterstock

More from Business

More from Scrip